PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28770977
OWN - NLM
STAT- MEDLINE
DA  - 20170803
DCOM- 20170808
LR  - 20170808
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 5
DP  - 2017 Aug 03
TI  - Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
PG  - 494-5
LID - 10.1056/NEJMc1707247 [doi]
FAU - Lofgren, Bo
AU  - Lofgren B
FAU - Pareek, Manan
AU  - Pareek M
FAU - Larsen, Jacob Moesgaard
AU  - Larsen JM
LA  - eng
PT  - Letter
PT  - Comment
DEP - 20170803
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Anticoagulants)
RN  - 0 (Benzimidazoles)
RN  - 11P2JDE17B (beta-Alanine)
RN  - 5Q7ZVV76EI (Warfarin)
RN  - I0VM4M70GC (Dabigatran)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Apr 27;376(17 ):1627-1636. PMID: 28317415
CIN - N Engl J Med. 2017 Aug 3;377(5):495-6. PMID: 28767343
MH  - Anticoagulants
MH  - *Atrial Fibrillation
MH  - Benzimidazoles
MH  - Catheter Ablation
MH  - Dabigatran
MH  - Humans
MH  - Treatment Outcome
MH  - *Warfarin
MH  - beta-Alanine
EDAT- 2017/08/05 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/05 06:00
PST - epublish
SO  - N Engl J Med. 2017 Aug 3;377(5):494-5. doi: 10.1056/NEJMc1707247.